This inventor holds 1 USPTO granted patent. Top assignee: Ariad Pharmaceuticals, Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Craig S. Takeuchi: Innovator in Signal Transduction Inhibitors
Introduction
Craig S. Takeuchi is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the area of signal transduction inhibitors. His work focuses on developing compounds that can inhibit intracellular signal transduction, which is crucial for various therapeutic applications.
Latest Patents
Craig S. Takeuchi holds a patent for "Signal transduction inhibitors, compositions containing them." This invention concerns compounds designed to inhibit intracellular signal transduction, especially those mediated by molecular interactions involving phosphotyrosine-containing proteins. The patent also relates to pharmaceutical compositions containing these compounds and outlines prophylactic and therapeutic methods for their administration in both human and veterinary medicine. The compounds are defined by a specific formula, which is detailed in the patent documentation.
Career Highlights
Takeuchi is associated with Ariad Pharmaceuticals, Inc., where he has contributed to innovative research and development in the pharmaceutical industry. His work has been instrumental in advancing the understanding and application of signal transduction inhibitors.
Collaborations
Throughout his career, Craig has collaborated with notable colleagues, including Regine Bohacek and Virginia A. Jacobsen. These collaborations have further enhanced the research and development efforts at Ariad Pharmaceuticals.
Conclusion
Craig S. Takeuchi's contributions to the field of signal transduction inhibitors highlight his role as an important inventor in the pharmaceutical industry. His innovative work continues to impact therapeutic methods and pharmaceutical compositions.